These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 11253746

  • 1. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ, Mittermayr M, Hoffmann G, Schobersberger W.
    Wien Klin Wochenschr; 2001 Feb 15; 113(3-4):90-6. PubMed ID: 11253746
    [Abstract] [Full Text] [Related]

  • 2. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H, Ninomiya H, Abe T, Saito K, Shishido H, Moriyama Y, Shibata A, Motoyoshi K, Nagata N, Miura Y.
    Int J Hematol; 1999 Feb 15; 69(2):81-8. PubMed ID: 10071455
    [Abstract] [Full Text] [Related]

  • 3. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
    Kuritzkes DR.
    Clin Infect Dis; 2000 Feb 15; 30(2):256-60. PubMed ID: 10671324
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E, Rom-Kedar V.
    Clin Cancer Res; 2008 Oct 15; 14(20):6354-63. PubMed ID: 18927273
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F, Tiseo M.
    Crit Rev Oncol Hematol; 2006 Jun 15; 58(3):221-30. PubMed ID: 16697211
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Akasheh M, Eastwood D, Vesole DH.
    Bone Marrow Transplant; 2003 Jan 15; 31(2):113-6. PubMed ID: 12621492
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Granulocytic growth factors and cancer-related neutropenia: limited effects.
    Prescrire Int; 2006 Oct 15; 15(85):189-91. PubMed ID: 17128529
    [Abstract] [Full Text] [Related]

  • 17. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
    Derici U, Ayerdem F, Arinsoy T, Reis KA, Dalgic A, Sindel S.
    Haematologia (Budap); 2002 Oct 15; 32(4):557-60. PubMed ID: 12803133
    [Abstract] [Full Text] [Related]

  • 18. [Immunoglobulin concentrate and G-CSF].
    Yamazaki M, Funada H.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():321-5. PubMed ID: 17455639
    [No Abstract] [Full Text] [Related]

  • 19. Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia.
    Cappozzo C.
    Oncol Nurs Forum; 2004 May 28; 31(3):569-76. PubMed ID: 15146222
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W.
    Transfusion; 2006 Nov 28; 46(11):1909-14. PubMed ID: 17076845
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.